The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells.
Tumor cells exhibit at least two distinct modes of migration when invading the 3D environment. A single tumor cell's invasive strategy follows either mesenchymal or amoeboid patterns. Certain cell types can use both modes of invasiveness and undergo transitions between them. This work outlines the signaling pathways involved in mesenchymal and amoeboid types of tumor cell motility and summarizes the molecular mechanisms that are involved in transitions between them. The focus is on the signaling of the Rho family of small GTPases that regulate the cytoskeleton-dependent processes taking place during the cell migration. The multiple interactions among the Rho family of proteins, their regulators and effectors are thought to be the key determinants of the particular type of invasiveness. Mesenchymal and amoeboid invasive strategies display different adhesive and proteolytical interactions with the surrounding matrix and the alterations influencing these interactions can also lead to the transitions.
Panková
K
K
Department of Cell Biology, Faculty of Science, Charles University in Prague, Prague, Czech Republic.
Rösel
D
D
Novotný
M
M
Brábek
Jan
J
D045744:Cell Line, Tumor; D002465:Cell Movement; D003599:Cytoskeleton; D006801:Humans; D009361:Neoplasm Invasiveness; D015398:Signal Transduction; D020744:rac GTP-Binding Proteins / Q000378:metabolism
D020744:rac GTP-Binding Proteins
Mol Cancer Res. 2008 Sep;6(9):1410-20
18819929
J Biol Chem. 1996 Aug 23;271(34):20246-9
8702756
J Leukoc Biol. 1997 Feb;61(2):188-200
9021925
EMBO J. 2002 May 15;21(10):2373-82
12006490
Nat Cell Biol. 2008 Feb;10(2):127-37
18204440
Cell. 1999 Apr 16;97(2):221-31
10219243
Curr Biol. 2006 Aug 8;16(15):1515-23
16890527
Nat Cell Biol. 2005 Mar;7(3):255-61
15723050
Mol Biol Cell. 2008 May;19(5):2003-13
18305103
Int J Biochem Cell Biol. 2008;40(3):344-9
17419089
Mol Cell Biol. 1998 Jan;18(1):130-40
9418861
Methods Enzymol. 2006;406:437-47
16472676
J Cell Biol. 2007 Jan 1;176(1):35-42
17190792
Biochem Soc Trans. 2004 Jun;32(Pt3):416-20
15157150
Cell Struct Funct. 1999 Oct;24(5):345-57
15216892
Science. 1996 Jul 12;273(5272):245-8
8662509
Oncogene. 2006 Sep 21;25(42):5726-40
16652152
J Leukoc Biol. 2001 Oct;70(4):491-509
11590185
J Biol Chem. 1999 Oct 1;274(40):28071-4
10497155
Mol Biol Cell. 2006 Nov;17(11):4675-85
16914516
J Cell Sci. 2005 Jun 15;118(Pt 12):2579-87
15928049
J Cell Biol. 2009 Apr 6;185(1):11-9
19332889
Curr Biol. 2008 Oct 14;18(19):1456-65
18835169
Biophys J. 2008 Dec;95(11):5374-84
18775961
Science. 1996 Sep 13;273(5281):1551-5
8703217
Cell. 1995 Apr 7;81(1):53-62
7536630
J Cell Sci. 2003 Mar 1;116(Pt 5):813-22
12571279
J Biol Chem. 2006 Jul 7;281(27):18652-9
16698790
Cell. 1992 Aug 7;70(3):401-10
1643658
Cell Motil Cytoskeleton. 1998;41(2):181-93
9786092
J Cell Biol. 2003 Jan 20;160(2):267-77
12527751
EMBO J. 1998 Dec 1;17(23):6932-41
9843499
J Cell Sci. 2001 Dec;114(Pt 24):4533-42
11792818
Immunology. 1994 Aug;82(4):617-24
7835926
Cancer Res. 2002 Apr 1;62(7):2125-30
11929834
Cell Mol Life Sci. 2009 Feb;66(3):370-4
19151919
Cell Motil Cytoskeleton. 1996;33(1):22-9
8824731
J Cell Biol. 2007 Jul 2;178(1):23-30
17606864
Eur J Cell Biol. 2008 Sep;87(8-9):669-76
18295931
J Cell Biol. 1984 Sep;99(3):894-9
6381508
Cell Mol Life Sci. 2006 Feb;63(4):449-68
16416030
Microsc Res Tech. 1998 Dec 1;43(5):369-78
9858334
Cell. 1996 May 31;85(5):683-93
8646777
Nature. 1997 Feb 6;385(6616):537-40
9020360
Nat Cell Biol. 2003 Aug;5(8):711-9
12844144
J Cell Biol. 2006 Nov 6;175(3):477-90
17088428
Trends Cell Biol. 1998 Feb;8(2):51-4
9695809
Cell. 2008 Oct 31;135(3):510-23
18984162